Many people find out they have diabetes not because of dramatic symptoms, but because a routine blood test returns an abnormal result. While classic warning signs like excessive thirst, frequent urination, and unexplained weight loss do occur, roughly one to two percent of U.S. adults are walking around with undiagnosed diabetes, and up to 90 percent of all cases are eventually caught through screening rather than symptom-driven visits.1PubMed Central. Undiagnosed Diabetes in U.S. Adults: Prevalence and Trends Understanding both the body’s signals and the tests that confirm a diagnosis is worth your time, because the gap between when diabetes starts and when it gets caught can have real consequences.
The Classic Warning Signs
The textbook symptoms of uncontrolled diabetes center on what excess glucose does to your body’s plumbing. When blood sugar climbs above roughly 180 mg/dL, your kidneys can no longer reabsorb all the glucose filtering through them. The overflow pulls extra water along with it, which is why you urinate more often and in larger volumes. That fluid loss triggers intense thirst, and the cycle feeds itself: you drink more, you urinate more.2African Journal of Diabetes Medicine. Polyuria and Diabetes: Understanding the Connection and Implications Alongside this, you may notice unexplained weight loss (especially in type 1 diabetes), persistent fatigue, and blurred vision.
The vision changes are worth a closer look because they confuse people. Shifts in blood sugar alter the shape of the lens inside your eye by changing how much fluid it absorbs. Some people become more nearsighted, others more farsighted, and the direction of the shift can vary from person to person. These fluctuations in visual clarity can actually be one of the first detectable signs of diabetes, sometimes showing up before other symptoms become obvious.3Taylor & Francis Online (Semin Ophthalmol). Refractive Changes Associated with Diabetes Mellitus If your glasses prescription suddenly seems wrong and your optometrist can’t find a structural reason, it’s worth asking for a blood sugar check.
Other symptoms that people often dismiss include slow-healing cuts or sores, frequent yeast infections or urinary tract infections, tingling or numbness in the hands and feet, and patches of darkened skin, particularly around the neck, armpits, or groin. That darkened, velvety skin has a name: acanthosis nigricans, and it’s one of several skin changes linked to insulin resistance. Skin tags, hormonal acne, and thinning hair can also be visible markers that your body isn’t processing insulin well.4PubMed Central. Skin Manifestations of Insulin Resistance: From a Biochemical Stance to a Clinical Diagnosis and Management These skin signs won’t confirm diabetes on their own, but they’re signals that further testing is warranted.
Why You Can Have Diabetes and Feel Fine
Here’s the frustrating part: type 2 diabetes often develops so gradually that your body adjusts to mildly elevated blood sugar without sounding any obvious alarms. You might feel a bit more tired or thirsty than usual and chalk it up to age or stress. This is why screening matters so much. Studies of people newly diagnosed with type 2 diabetes consistently find that complications have already begun before the person ever felt sick. In one study, about 30 percent of newly diagnosed patients already had some form of microvascular complication, including retinopathy in roughly 5 percent and kidney involvement in about 10 percent.5PubMed. Prevalence and risk factors for diabetic microvascular complications in newly diagnosed type II diabetes mellitus Another study found neuropathy symptoms in over half of newly diagnosed patients and hypertension in nearly 60 percent.6International Journal of Diabetes Mellitus. Chronic complications of diabetes mellitus in newly diagnosed patients
Those numbers make it clear that diabetes doesn’t politely wait for you to notice before doing damage. The years of elevated blood sugar that precede a diagnosis are not idle. Small blood vessels in the eyes, kidneys, and nerves are already under strain. This is the core argument for proactive screening rather than waiting for symptoms.
Who Should Get Screened and When
The U.S. Preventive Services Task Force recommends screening for prediabetes and diabetes in adults aged 35 to 70 who are overweight or obese, even if they feel perfectly healthy. That age threshold was lowered from 40 in 2021. The task force also suggested that clinicians consider earlier screening for racial and ethnic groups that face higher diabetes risk at younger ages or lower body weights.7PubMed Central. Screening for Prediabetes and Diabetes: Clinical Performance and Implications for Health Equity The American Diabetes Association goes further, recommending screening for all adults starting at age 35, and earlier if you have risk factors like a family history of diabetes, a history of gestational diabetes, polycystic ovary syndrome, or belonging to a higher-risk ethnic group.
If your results come back normal, repeat testing every three years is generally recommended, though your doctor may test sooner if your risk profile changes. If you’re in the prediabetes range, annual testing is standard. This isn’t a one-and-done situation: your glucose metabolism can shift over years, and catching the transition from prediabetes to diabetes early gives you the best shot at managing it with lifestyle changes alone.
The Three Standard Diagnostic Tests
Doctors use three main blood tests to diagnose diabetes, and they don’t always agree with each other. Understanding what each one measures helps explain why.
- Fasting plasma glucose (FPG): You fast for at least eight hours, then a blood sample is drawn. A level of 100 to 125 mg/dL indicates prediabetes; 126 mg/dL or higher on two separate occasions indicates diabetes.
- Oral glucose tolerance test (OGTT): After an overnight fast, you drink a sugary solution containing 75 grams of glucose. Blood is drawn two hours later. A reading of 140 to 199 mg/dL suggests prediabetes; 200 mg/dL or above points to diabetes.
- HbA1c (glycated hemoglobin): This measures what percentage of your hemoglobin has glucose attached to it, reflecting your average blood sugar over the previous two to three months. An HbA1c of 5.7 to 6.4 percent indicates prediabetes; 6.5 percent or higher indicates diabetes. No fasting is required.
The disagreements between these tests are not trivial. A study in Thai adults found that fasting glucose missed about 55 percent of diabetes cases that the OGTT caught, and roughly 46 percent of prediabetes cases.8PubMed Central. Detecting Prediabetes and Diabetes: Agreement between Fasting Plasma Glucose and Oral Glucose Tolerance Test in Thai Adults That’s because fasting glucose only captures how well your body handles sugar in a resting state. Some people have normal fasting levels but their blood sugar spikes dramatically after eating, and only the OGTT (or a postmeal check) catches that pattern. Each test is also subject to biological variation from day to day, and the consistency of classification can differ depending on which diagnostic criteria are applied.9Scientific Reports. Impact of analytical and biological variations on classification of diabetes using fasting plasma glucose, oral glucose tolerance test and HbA1c
In practice, most clinics start with fasting glucose or HbA1c because they’re simpler. The OGTT is more cumbersome (you have to sit in a lab for two hours) but catches more cases. If one test comes back borderline, asking for a second type of test is reasonable.
When HbA1c Gets It Wrong
HbA1c is convenient and widely used, but it has a significant blind spot: it depends on hemoglobin behaving normally. Anything that alters the lifespan or structure of your red blood cells can throw the number off. Iron-deficiency anemia, for instance, tends to falsely raise HbA1c because red blood cells live longer and accumulate more glucose. One study found that in people with anemia, the specificity of the 6.5 percent HbA1c cutoff dropped to about 81 percent, compared with 93 percent in people without anemia.10Diabetes & Metabolism Journal. Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects That means more false positives in the anemic group.
Hemoglobin variants, which are common in people of African, Southeast Asian, and Mediterranean descent, present another challenge. Depending on the specific variant and the lab method used, HbA1c can read falsely high or falsely low. In one analysis, certain hemoglobin variants like Hb D and Hb Louisville gave HbA1c results that didn’t correlate with fasting glucose at all when measured by one common lab technique, though a different method corrected most of the errors.11PubMed Central. Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method Another study found that heterozygous hemoglobin E produced significantly lower HbA1c with one method compared to another, while hemoglobin S showed the reverse pattern.12PubMed Central. Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements
If you carry a hemoglobin variant or have chronic anemia, your doctor should be aware and may need to rely more on fasting glucose or the OGTT. An alternative blood marker called fructosamine, which reflects glycemic control over a shorter window of about two to three weeks, is unaffected by hemoglobin abnormalities. Studies in people with sickle cell trait have confirmed that fructosamine performs as well as HbA1c for identifying uncontrolled blood sugar and diagnosing diabetes, with no difference in accuracy between those with and without the trait.13PubMed Central. Serum fructosamine and glycemic status in the presence of the sickle cell mutation Glycated albumin is another short-term marker with similar utility.14PubMed Central. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
Figuring Out Which Type You Have
Getting a diabetes diagnosis is one thing; figuring out which type is another, and it matters because the treatment approaches differ. In most adults, type 2 is assumed if you’re older, overweight, and your blood sugar climbed gradually. Type 1 is suspected when onset is sudden, the person is younger and leaner, and there’s rapid progression to needing insulin. But these stereotypes fail more often than people realize.
Up to 10 percent of adults diagnosed with apparent type 2 diabetes actually have a slow-developing form of autoimmune diabetes called latent autoimmune diabetes in adults, or LADA. These people are often misdiagnosed because they don’t fit the classic type 1 profile: they’re adults, they don’t initially need insulin, and they may be mildly overweight. Clues that suggest LADA include age under 50, a lean build, a personal or family history of autoimmune diseases, and a poor response to oral diabetes medications.15PubMed Central. Recognizing and Appropriately Treating Latent Autoimmune Diabetes in Adults The confirmatory test is a blood draw for autoantibodies, most commonly antibodies against an enzyme called glutamic acid decarboxylase (GAD). When the type of diabetes is ambiguous, autoantibody testing is the recommended approach to distinguish between type 1 and type 2.16The BMJ. Distinguishing between type 1 and type 2 diabetes
There’s also a less well-known category called MODY (maturity-onset diabetes of the young), which accounts for an estimated one to two percent of all diabetes cases. MODY is caused by a single gene mutation inherited from one parent, and it runs strongly in families. It often shows up in teenagers or young adults who are not overweight and don’t have autoantibodies. Specific genetic mutations determine how severe the diabetes is and whether it responds to certain oral medications or requires insulin.17The BMJ. Diagnosis and management of maturity onset diabetes of the young (MODY) One common MODY subtype caused by a glucokinase gene mutation produces mildly elevated fasting glucose that rarely progresses and often needs no treatment at all. Genetic testing can identify the specific mutation, and in many cases the diagnosis changes both the treatment plan and the outlook for affected family members.18PubMed Central. Differentiating Among Type 1, Type 2 Diabetes, and MODY
Getting the type right isn’t academic: a person with LADA who is treated only with oral medications will progress to needing insulin faster and may have worse outcomes than if insulin had been introduced earlier. A person with glucokinase-MODY may be taking medication they don’t need. If your diabetes diagnosis doesn’t quite fit the expected pattern, asking about autoantibody testing or C-peptide measurement is reasonable. C-peptide is released by the pancreas in equal amounts to insulin, and a very low level suggests the body has stopped making its own insulin, which points toward type 1 or advanced LADA rather than type 2.19PubMed Central. C-peptide in Precision Diabetes Care and Beyond: A Comprehensive Review
Gestational Diabetes and What Comes After
Pregnancy creates its own category of diabetes risk. Gestational diabetes develops during pregnancy in women who didn’t have diabetes before, and it’s detected through glucose screening that’s now routine in prenatal care, usually between 24 and 28 weeks. The condition typically resolves after delivery, but the story doesn’t end there.
About a third of women with gestational diabetes have prediabetes when tested at six to nine weeks postpartum, and the risk varies depending on the pattern of their glucose elevations during pregnancy. Women who had both elevated fasting glucose and elevated post-meal glucose during pregnancy carried the highest postpartum risk, with roughly 56 percent meeting prediabetes criteria shortly after delivery.20JAMA Network Open. Early Postpartum Glucose Tolerance Reclassification by Gestational Diabetes Subtype The recommended follow-up is a glucose tolerance test at six to twelve weeks after giving birth.21PubMed Central. Postpartum Screening for Diabetes Among Women With a History of Gestational Diabetes Mellitus
Over the longer term, having had gestational diabetes raises the risk of developing type 2 diabetes substantially. A meta-analysis found that women with a history of gestational diabetes had roughly nine times the risk of developing type 2 diabetes compared to women whose pregnancies were unaffected.22PubMed Central. Risk of type 2 diabetes mellitus after gestational diabetes mellitus: A systematic review & meta-analysis Studies have found that 16 to 30 percent of women with gestational diabetes develop type 2 diabetes within five to ten years, with cases continuing to accumulate even later.21PubMed Central. Postpartum Screening for Diabetes Among Women With a History of Gestational Diabetes Mellitus If you had gestational diabetes, annual or near-annual screening for the rest of your life is a good idea, not something to let slip once the baby is older.
Drug-Induced and Secondary Diabetes
Not all diabetes fits neatly into the type 1, type 2, or gestational boxes. Certain medications can push blood sugar into the diabetic range, and steroid-induced diabetes is probably the most common example. Glucocorticoids like prednisone, used to treat inflammation, asthma flares, autoimmune conditions, and organ transplant rejection, can cause dramatic post-meal glucose spikes. The hyperglycemia sometimes catches doctors off guard, leading to preventable hospital admissions and complications.23PubMed Central. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment Other medications that can raise blood sugar include certain antipsychotics, thiazide diuretics, and some immunosuppressants.
If you’re starting a medication known to affect blood sugar, ask your doctor whether monitoring is warranted. Steroid-induced diabetes sometimes resolves when the medication is stopped, but in other cases it unmasks an underlying tendency toward type 2 that was already developing. Either way, knowing what’s happening with your glucose while you’re on these drugs prevents surprises.
What Home Glucose Meters Can and Cannot Tell You
A finger-prick glucose meter from the pharmacy can give you a quick snapshot of your blood sugar, and many people wonder whether they can use one to screen themselves. The short answer: a good-quality meter is useful for spotting blood sugar that’s clearly abnormal, but it isn’t a substitute for a lab test.
The accuracy of home meters varies more than most people expect. A comparison of 17 point-of-care glucose meters found that their average error rates ranged from about 6 percent to 21 percent, with accuracy tending to be worse at low blood sugar levels.24PubMed Central. Comparative Accuracy of 17 Point-of-Care Glucose Meters An older study of meters during hypoglycemia found substantial differences between brands, with some devices placing nearly all readings within 20 percent of the true value and others hitting that mark less than half the time.25PubMed. Accuracy of home blood glucose meters during hypoglycemia Non-invasive monitors that claim to measure glucose without a finger prick have generally fared worse. One evaluation found that a non-invasive home monitor produced readings significantly higher than the lab reference, with only about 18 percent of readings meeting the international accuracy standard.26PubMed Central. Accuracy of a Non-Invasive Home Glucose Monitor for Measurement of Blood Glucose
What does this mean in practice? If you prick your finger and see a fasting reading well above 126 mg/dL, that’s a strong signal to see a doctor. But a borderline reading on a home meter doesn’t confirm or rule out diabetes. Lab-grade testing is the only reliable diagnostic standard. Home meters are designed for people who already have a diagnosis and need to track day-to-day trends, not for making a diagnosis from scratch.
Continuous Glucose Monitors and the Future of Early Detection
Continuous glucose monitors, the small sensors worn on the arm or abdomen that track glucose every few minutes, are increasingly popular among people with diabetes. Researchers are now exploring whether these devices could help catch prediabetes earlier than traditional tests do. The logic is appealing: a single fasting glucose measurement captures one moment in time, but a continuous monitor reveals patterns, particularly those dangerous post-meal spikes that a fasting test misses entirely.
One Stanford-led study found that even people considered normoglycemic by standard measures spent a surprising amount of time in the prediabetic and diabetic glucose ranges when monitored continuously, with glucose reaching prediabetic levels about 15 percent of the time.27PubMed Central. Glucotypes reveal new patterns of glucose dysregulation This suggests that standard tests may underestimate how many people are already experiencing glucose dysregulation. Researchers are developing metrics beyond simple averages, looking at how much and how quickly glucose swings throughout the day, to catch prediabetes at its earliest stages.28PubMed Central. Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics? Machine-learning models trained on these continuous data have shown promising accuracy in distinguishing healthy individuals from those with prediabetes, outperforming traditional single-measurement tests.29PubMed. From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring Data
Continuous monitors aren’t yet recommended as a standard screening tool for the general population. They’re expensive, require a prescription in most countries, and the research on using them for diagnosis rather than management is still in its early stages. But the evidence that glucose variability patterns carry diagnostic information beyond what a single test captures is growing, and it’s likely that the way we screen for diabetes will look different in a decade. For now, if you’ve had borderline test results and want a richer picture of what your blood sugar actually does throughout the day, discussing a short trial of continuous monitoring with your doctor is a reasonable conversation to have.
How Diabetes Was Detected Before Blood Tests
For most of human history, the only way to detect diabetes was its most conspicuous symptom: copious, sweet-tasting urine. Ancient Indian medical texts described the condition, and Aretaeus of Cappadocia gave it its name in the second century, choosing the Greek word for “siphon” because the body seemed to be draining fluids straight through.30PubMed Central. Milestones in the history of diabetes mellitus: The main contributors For centuries, Galen’s view prevailed: diabetes was a kidney disease, a failure of the kidneys to retain what they should. In 1674, Thomas Willis reintroduced the observation that diabetic urine tasted “as if imbued with honey” and proposed, importantly, that the sweetness originated in the blood before reaching the urine. A century later, Matthew Dobson confirmed that the sweetness was due to sugar and that it appeared in the blood first.31PubMed. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease That insight, that diabetes is a blood disease manifesting through the kidneys rather than a kidney disease itself, took roughly 1,500 years to establish. The diagnostic tools available today are a dramatic improvement, but the fundamental challenge remains the same: catching elevated blood sugar before it quietly damages the body’s smallest blood vessels.